# The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer

> **NCT02687321** · — · UNKNOWN · sponsor: **Brno University Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **OTHER:** Determination of CA 125 and HE4, Computed tomography

## Key facts

- **NCT ID:** NCT02687321
- **Lead sponsor:** Brno University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687321, "The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02687321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*